Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $387.7000 (-2.56%) ($385.0200 - $397.8900) on Wed. Oct. 29, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.03% (three month average) | RSI | 62 | Latest Price | $387.7000(-2.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 8.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(38%) XBI(37%) QQQ(31%) SPY(30%) XLK(28%) | Factors Impacting REGN price | REGN will decline at least -1.015% in a week (0% probabilities). VIXM(-12%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.015% (StdDev 2.03%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
5 Day Moving Average | $397.84(-2.55%) | 10 Day Moving Average | $384.1(0.94%) | 20 Day Moving Average | $366.73(5.72%) | To recent high | -4.8% | To recent low | 27.3% | Market Cap | $41.107b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |